Vitafusion ‘Clinically Proven Absorption’ Claim Fails In C&D Appeal Of Industry Self-Regulation Review
C&D Also Argued NAD Erred In Initial Review Allowing Pharmavite To Expand Challenge
Executive Summary
Church & Dwight will comply with National Advertising Review Board decision to discontinue claim for vitafusion supplements. The panel rejected C&D’s argument that any amount of vitamin absorption is “clinically meaningful” and deferred to the National Advertising Division on C&D’s procedural challenge.